Stealth is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of mitochondrial dysfunctions.
Business Model:
Revenue: $21.1M
Employees: 11-50
Address: 140 Kendrick Street
City: Needham
State: MA
Zip: 02494
Country: US
Stealth is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of mitochondrial dysfunctions.
Contact Phone:
+16176006888
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/14/2019
Ticker Symbol:
MITO
IPO Price:
$12/share
Amount Raised:
$78M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|